DIURIL (chlorothiazide) by Bausch Health is clinical pharmacology the mechanism of the antihypertensive effect of thiazides is unknown. First approved in 1961.
Drug data last refreshed 18h ago · AI intelligence enriched 20h ago
DIURIL (chlorothiazide) is a thiazide diuretic oral suspension approved in 1961 that reduces blood pressure by increasing sodium and chloride excretion in the distal renal tubule. The mechanism of antihypertensive effect remains incompletely understood, though diuresis begins within 2 hours and peaks at 4 hours. It is a foundational antihypertensive agent with over 60 years of clinical use.
Loss of exclusivity is imminent; the brand team is likely in maintenance mode with minimal expansion headcount.
CLINICAL PHARMACOLOGY The mechanism of the antihypertensive effect of thiazides is unknown. DIURIL does not usually affect normal blood pressure. DIURIL affects the distal renal tubular mechanism of electrolyte reabsorption. At maximal therapeutic dosage all thiazides are approximately equal in…
Thiazide Diuretic
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufactured at Two Sites: Viatris and Neolpharma
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes.
A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide
Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
Worked on DIURIL at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DIURIL offers limited career growth and visibility given its legacy status and approaching loss of exclusivity. Roles focus on cost management, generic transition planning, and regulatory maintenance rather than innovation or market expansion.